Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for...

|About: Baxter International Inc (BAX)|By:, SA News Editor

Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for hemophilia A. The firm says the phase I trial is the first step in assessing if the drug can be infused less frequently.